Baseline gut microbiome alpha diversity predicts chemotherapy-induced gastrointestinal symptoms in patients with breast cancer.
Otto-Dobos LD, Strehle LD, Loman BR, Seng MM, Sardesai SD, Williams NO, Gatti-Mays ME, Stover DG, Sudheendra PK, Wesolowski R, Andridge RR, Bailey MT, Pyter LM.
Otto-Dobos LD, et al. Among authors: andridge rr.
NPJ Breast Cancer. 2024 Nov 15;10(1):99. doi: 10.1038/s41523-024-00707-6.
NPJ Breast Cancer. 2024.
PMID: 39548124
Free PMC article.